Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Frontiers in Pharmacology|April 10, 2023
Pharmacokinetic comparison of sitagliptin and metformin HCl extended-release tablets versus JANUMET<sup>®</sup> XR in healthy volunteers under fasting and fed conditionsLinling Que, Wei Qin, Yunfei Shi, et al.
Asian Journal of Psychiatry|September 8, 2024
Dynamics of symptom network in patients with first-episode schizophrenia: Insight from the CNFEST projectZhenqing Zhang, Bingjie Huang, Weiwei Wu, et al.
Schizophrenia (Heidelberg, Germany)|July 22, 2025
Neurocognition as a major predictor of 8-week response to antipsychotics for drug-naïve first-episode schizophrenia using machine learningXianghe Wang, Tianqi Gao, Xiaodong Guo, et al.
Food Science & Nutrition|May 20, 2022
Physicochemical property and antioxidant activity of polysaccharide from the seed cakes of <i>Camellia oleifera</i> AbelMeidan Wei, Yuxin Hu, Wanshuang Zou, et al.
Psych Journal|October 9, 2025
Dysfunctions of Reward Motivation Adaptation in Patients With SchizophreniaYiming Pan, Hui Wang, Qi Zhou, et al.
Frontiers in Psychiatry|October 13, 2022
Negative symptoms correlate with altered brain structural asymmetry in amygdala and superior temporal region in schizophrenia patientsZetao Huang, Dun Ruan, Bingjie Huang, et al.
Frontiers in Psychiatry|May 1, 2024
Eye movements as predictor of cognitive improvement after cognitive remediation therapy in patients with schizophreniaJiahui Zhu, Jinhao Li, Li Zhou, et al.
Schizophrenia Research. Cognition|November 19, 2024
Humor processing and its relationship with clinical features in patients with first-episode schizophreniaYunfei Ji, Bingjie Huang, Jia Huang, et al.
Asian Journal of Psychiatry|April 24, 2023
Weight changes following treatment with aripiprazole, risperidone and olanzapine: A 12-month study of first-episode schizophrenia patients in ChinaTianhang Zhou, Chengcheng Pu, Zetao Huang, et al.
Neuropsychiatric Disease and Treatment|May 20, 2026
Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode SchizophreniaWanHeng Hu, BingJie Huang, XiaoDong Guo, et al.
Pageof 3